← Browse by Condition
Medical Condition
hr positive her2 negative advanced breast cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT06805812
Recruiting
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
Enrollment
3,500 pts
Location
Italy
Sponsor
Fondazione IRCCS Istituto Nazi...
NCT06625775 Phase 1
Recruiting
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Enrollment
392 pts
Location
United States, Austr...
Sponsor
TheRas, Inc., d/b/a BBOT (Brid...